Malignant superior vena cava syndrome (SVCS) is a clinical problem that results from the
obstruction of blood flow in the superior vena cava by an underlying malignancy. This may …

Palliative care pertains to the holistic multidimensional concept of “patient-centred” care. It is
an interprofessional specialty, primarily aiming to improve quality of care for cancer patients …

Long-term disease-free survival (DFS) of 19 years and 8 months is achieved in an Indian
male young patient with Acute Myeloid Leukemia (AML) with a grade 2 Superior Vena Cava …

Aim: To define high tumor burden (HTB) in non-small-cell lung cancer. Methods: A total of
five oncologists initiated the project, selecting 66 participants, and elaborated a …

Primary mediastinal B-cell lymphoma (PMBL) is an uncommon entity of aggressive large B-
cell lymphoma (LBCL), representing approximately 2–4% of newly diagnosed non-Hodgkin …

Malignant superior vena cava syndrome (SVCS) is no longer considered a medical
emergency in most cases because it rarely leads to life-threatening complications. However …

Respiratory diseases and cardiovascular diseases (CVDs) have high prevalence and share
common risk factors. In some respiratory diseases such as sleep apnoea and COPD, the …

Background The location and type of a tumor influence the prognosis of lung cancer.
Primary Central Lung Tumors (PCLTs) are correlated with poor prognoses and certain …

Purpose Superior vena cava (SVC) syndrome is a constellation of symptoms that results
from partial or complete SVC obstruction. Endovascular SVC stenting is an effective …

The treatment of malignant superior vena cava syndrome (SVCS) revolves around
radiotherapy and chemotherapy to relieve symptoms with surgery being ruled out due to the …